Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2012 by Dubai Health Authority.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Sivakami A Pai, Dubai Health Authority
ClinicalTrials.gov Identifier:
NCT01707745
First received: September 22, 2012
Last updated: October 15, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)